Design Therapeutics, Inc. (DSGN)

Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $685.15 million. The enterprise value is $465.06 million.

Market Cap	685.15M
Enterprise Value	465.06M

Important Dates

The last earnings date was Tuesday, April 28, 2026, after market close.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

DSGN has 62.46 million shares outstanding. The number of shares has increased by 3.26% in one year.

Current Share Class	62.46M
Shares Outstanding	62.46M
Shares Change (YoY)	+3.26%
Shares Change (QoQ)	+4.60%
Owned by Insiders (%)	14.26%
Owned by Institutions (%)	53.14%
Float	35.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.14
P/TBV Ratio	3.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.28, with a Debt / Equity ratio of 0.01.

Current Ratio	22.28
Quick Ratio	22.05
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31.26% and return on invested capital (ROIC) is -21.72%.

Return on Equity (ROE)	-31.26%
Return on Assets (ROA)	-20.93%
Return on Invested Capital (ROIC)	-21.72%
Return on Capital Employed (ROCE)	-35.58%
Weighted Average Cost of Capital (WACC)	13.75%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +204.72% in the last 52 weeks. The beta is 1.74, so DSGN's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+204.72%
50-Day Moving Average	12.35
200-Day Moving Average	9.08
Relative Strength Index (RSI)	38.83
Average Volume (20 Days)	1,235,604

Short Selling Information

The latest short interest is 2.32 million, so 3.72% of the outstanding shares have been sold short.

Short Interest	2.32M
Short Previous Month	2.24M
Short % of Shares Out	3.72%
Short % of Float	6.57%
Short Ratio (days to cover)	4.89

Income Statement

Revenue	n/a
Gross Profit	-58.13M
Operating Income	-78.36M
Pretax Income	-69.71M
Net Income	-69.71M
EBITDA	-77.74M
EBIT	-78.36M
Earnings Per Share (EPS)	-$1.19

Balance Sheet

The company has $222.82 million in cash and $2.73 million in debt, with a net cash position of $220.09 million or $3.52 per share.

Cash & Cash Equivalents	222.82M
Total Debt	2.73M
Net Cash	220.09M
Net Cash Per Share	$3.52
Equity (Book Value)	218.05M
Book Value Per Share	3.49
Working Capital	216.86M

Cash Flow

In the last 12 months, operating cash flow was -$54.00 million and capital expenditures -$121,000, giving a free cash flow of -$54.12 million.

Operating Cash Flow	-54.00M
Capital Expenditures	-121,000
Depreciation & Amortization	620,000
Net Borrowing	n/a
Free Cash Flow	-54.12M
FCF Per Share	-$0.87

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.26%
Shareholder Yield	-3.26%
Earnings Yield	-10.17%
FCF Yield	-7.90%

Analyst Forecast

The average price target for DSGN is $21.00, which is 56.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	56.52%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1